DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bencyclane
Bencyclane
(12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Examination of Antimicrobial Activity of Selected Non-Antibiotic Medicinal Preparations
Partial Agreement in the Social and Public Health Field
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
(12) Patent Application Publication (10) Pub. No.: US 2014/0144429 A1 Wensley Et Al
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
WO 2014/085719 Al 5 June 2014 (05.06.2014) P O P C T
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
Page 1 FINLANDS FÖRFATTNINGSSAMLING Utgiven I Helsingfors
(12) United States Patent (10) Patent No.: US 8,383,154 B2 Bar-Shalom Et Al
I (Acts Whose Publication Is Obligatory) COMMISSION
SUPPLEMENTARY MATERIAL 1: Search Strategy
Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……
Calcium Channel Blockers Versus Other Classes of Drugs for Hypertension (Review)
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Florencio Zaragoza Dörwald Lead Optimization for Medicinal Chemists
Top View
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2016) Annotated for Statistical Reporting Purposes
Mining of High Throughput Screening Database Reveals AP-1 And
Peripheral Arterial Disease
'Cerebroactive' Drugs Clinical Pharmacology and Therapeutic Role in Cerebrovascular Disorders
Bencyclane — a New Aspect of the Mechanism of Action in Patients with Peripheral Arterial Occlusive Disease
Pharmaabkommen A1 E
Evidence Review E: Postnatal Management of Hypertension
Pharmaceutical Appendix to the Tariff Schedule 2
Customs Tariff - Schedule Xxi - 1
United States Patent (19) 11 Patent Number: 5,811,547 Nakamichi Et Al
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Bencyclane Fumarate (Rinnm) Rinogenic in Animals Or In-Vitro Systems
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2006) (Rev
Customs Tariff - Schedule Xxi - 1
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Pharmaceutical Appendix to the Tariff Schedule 2
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Effects of Bencyclane on Normal and Cevadine-Modified Na Channels in Frog Skeletal Muscle
Ligand P-Gp Inhibition
Benefits and Harms of Treating Blood Pressure in Older Adults Evidence-Based Synthesis Program APPENDIX A
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
ICD-10-CM Table of Drugs 2019
Evidence-Based Clinical Practice Guideline for the Treatment of Calcium Channel Blocker Poisoning
(12) United States Patent (10) Patent No.: US 6,572,880 B2 Murdock Et Al
Current Awareness in Clinical Toxicology Editors: Damian Ballam Msc and Allister Vale MD
Hu Zhu,1 Catherine Z. Chen1, Srilatha Sakamuru1, Anton Simeonov,1 Mathew D
L:\0900\0900PHARMAPPX .Wpd
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving